Rewiring enervated: Thinking LARGEr than myodystrophy

Journal of Neuroscience Research

Volumn 84, Issue 2, 2006, Pages 237-243

  Levedakou, Eleni N ^a   Popko, Brian ^a  

^a The University of Chicago Pritzker School of Medicine   (United States)

Author keywords

Glycosylation; Glycosyltransferase; Neuromuscular junction; Peripheral nerve; Schwann cells

Indexed keywords

ALPHA DYSTROGLYCAN; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; GLYCOSYLTRANSFERASE;

BRAIN MALFORMATION; CELL FUNCTION; CELL REGENERATION; CONGENITAL HEART MALFORMATION; EYE MALFORMATION; GENE DELETION; GENE EXPRESSION; GLYCOSYLATION; HUMAN; MUSCULAR DYSTROPHY; MUTANT; NERVE FIBER MEMBRANE; NERVE INJURY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SCHWANN CELL; SHORT SURVEY; TRANSGENE;

ANIMALS; CELL DIFFERENTIATION; GENE DELETION; GLYCOSYLTRANSFERASES; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; NEUROMUSCULAR JUNCTION; PERIPHERAL NERVOUS SYSTEM; SCHWANN CELLS; TRANSGENES;

EID: 33746395057     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20896     Document Type: Short Survey

References (47)

1. Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
2. Allamand V, Campbell KP. 2000. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet 9:2459-2467.
3. Anderson L, Anderson NG. 1977. High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci U S A 74:5421-5425.
4. Banks GB, Fuhrer C, Adams ME, Froehner SC. 2003. The postsynaptic submembrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin/dystrophin-associated complex. J Neurocytol 32:709-726.
5. Barresi R, Michele DE, Kanagawa M, Harper HA, Dovico SA, Satz JS, Moore SA, Zhang W, Schachter H, Dumanski JP, Cohn RD, Nishino I, Campbell KP. 2004. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 10:696-703.
6. Bradley WG, Jenkison M. 1975. Neural abnormalities in the dystrophic mouse. J Neurol Sci 25:249-255.
7. Browning CA, Grewal PK, Moore CJ, Hewitt JE. 2005. A rapid PCR method for genotyping the Large (myd) mouse, a model of glycosylation-deficient congenital muscular dystrophy. Neuromusc Disord 15: 331-335.
8. Burkin DJ, Kim JE, Gu M, Kaufman SJ. 2000. Laminin and α7β1 integrin regulate agrin-induced clustering of acetylcholine receptors. J Cell Sci 113:2877-2886.
9. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ. 2001. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 152:1207-1218.
10. Cartaud A, Coutant S, Petrucci TC, Cartaud J. 1998. Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse. J Biol Chem 273:11321-11326.
11. Chen Z-L, Strickland S. 2003. Laminin γ1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 163:889-899.
12. Cohn RD. 2005. Dystroglycan: important player in skeletal muscle and beyond. Neuromusc Disord 15:207-217.
13. Davidsson P, Fredman P, Collins VP, von Holst H, Mansson JE, Svennerholm L. 1989. Ganglioside composition in human meningiomas. J Neurochem 53:705-709.
14. Feltri ML, Graus Porta D, Previtali SC, Nodari A, Migliavacca B, Cassetti A, Littlewood-Evans A, Reichardt LF, Messing A, Quattrini A, Mueller U, Wrabetz L. 2002. Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J Cell Biol 156:199-209.
15. Grewal PK, Hewitt JE. 2002. Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim Biophys Acta 1573:216-224.
16. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE. 2001. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat Genet 28:151-154.
17. Hakomori S. 1996. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56:5309-5318.
18. Heinrichs DE, Yethon JA, Whitfield C. 1998. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol Microbiol 30:221-232.
19. myd mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum Mol Genet 11:2673-2687.
20. Imamura M, Araishi K, Noguchi S, Ozawa E. 2000. A sarcoglycan- dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet 9:3091-3100.
21. Jacobson C, Cote PD, Rossi SG, Rotundo RL, Carbonetto S. 2001. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152:435-450.
22. Jessen KR, Mirsky R. 1999. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 22:402-410.
23. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. 1995. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 270:27305-27310.
24. Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi M, Kobayashi YM, Muschler J, Durnanski JP, Michele DE, Oldstone MBA, Campbell KP. 2004. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117:953-964.
25. Kelly D, Chancellor K, Milatovich A, Francke U, Suzuki K, Popko B. 1994. Autosomal recessive neuromuscular disorder in a transgenic line of mice. J Neurosci 14:198-207.
26. Lane PW, Beamer TC, Myers DD. 1976. Myodystrophy, a new myopathy on chromosome 8 of the mouse. J Hered 67:135-138.
27. vls mice, spontaneous models for muscle, eye, and brain diseases. Mol Cel Neurosci 30:160-172.
28. Levedakou EN, Chen X-J, Soliven B, Popko B. 2005. Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects. Mol Cel Neurosci 28:757-769.
29. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F. 2003. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 12:2853-2861.
30. Martin PT, Sanes JR. 1997. Integrins mediate adhesion to agrin and modulate agrin signaling. Development 124:3909-3917.
31. Masaki T, Matsumura K, Saito F, Sunada Y, Shimizu T, Yorifuji H, Motoyoshi K, Kamakura K. 2000. Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration. Acta Neuropathol 99:289-295.
32. Masaki T, Matsumura K, Hirata A, Yamada H, Hase A, Arai K, Shimizu T, Yorifuji H, Motoyoshi K, Kamakura K. 2002. Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during development. Exp Neurol 174:109-117.
33. Merril CR, Goldman D, Sedman SA, Ebert MH. 1981. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science 211:1437-1438.
34. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. 2002. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422.
35. Montanaro F, Gee SH, Jacobson C, Lindenbaum MH, Froehner SC, Carbonetto S. 1998. Laminin and alpha-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway. J Neurosci 18:1250-1260.
36. Peyrard M, Seroussi E, Sandberg-Nordqvist AC, Xie YG, Han FY, Fransson I, Collins J, Dunham I, Kost-Alimova M, Imreh S, Dumanski JP. 1999. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci U S A 96:589-603.
37. Rath EM, Kelly D, Bouldin TW, Popko B. 1995. Impaired peripheral nerve regeneration in a mutant strain of mice (enr) with a Schwann cell defect. J Neurosci 15:7226-7237.
38. Rayburn HB, Peterson AC. 1978. Naked axons in myodystrophic mice. Brain Res 146:380-384.
39. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38:747-758.
40. Sasaki K, Kurata-Miura K, Ujita M, Angata K, Nakagawa S, Sekine S, Nishi T, Fukuda M. 1997. Expression cloning of cDNA encoding a human β-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc Natl Acad Sci U S A 94:14294-14299.
41. Seizinger BR, de la Monte S, Atkins L, Gusella JF, Martuza RL. 1987. Molecular genetic approach to human meningioma: loss of gene on chromosome 22. Proc Natl Acad Sci U S A 84:5419-5423.
42. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96:7532-7537.
43. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ. 2001. Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677-687.
44. Stirling C. 1975. Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice. J Anat 119:169-180.
45. Xu H, Wu XR, Wewer UM, Engvall E. 1994. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet 8:297-302.
46. Zhang H, Li X-J, Martin DB, Aebersold R. 2003. Identification and quantification of N-linked glycoproteins using hydrazide chemistry stable isotope labeling and mass spectrometry. Nat Biotechnol 21:660-666.
47. Zhang H, Yi EC, Li X-J, Mallick P, Kelly-Spratt KS, Masselon CD, Camp DG 2nd, Smith RD, Kemp CJ, Aebersold R. 2005. High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics 4:144-155.